saxenda glp 1 Teva Claims A First With US Launch Of Liraglutide For Weight Loss Biocon Marks GLP-1 Milestone With
Description
Check the syringe packaging

Tirzepatide (Mounjaro) has also been shown to significantly reduce the severity of sleep apnoea, mostly because weight loss puts less pressure on the airways

PMCID: PMC11034947

Sodium, potassium, and magnesium are the three most critical for GLP-1 users

Rossing P, Baeres FMM, Bakris G et al (2023) The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

Almost 95% of people who take GLP-1 drugs do not have negative effects, making side effects relatively rare